Navelbine is used in the treatment of non-small cell lung cancer and is given as an injection into a vein once a week. The recommended Navelbine dosage will depend on your height and weight, how you respond to the medication, and other factors. Your healthcare provider may give you other medications before your injection to help prevent side effects.
The dose of Navelbine® (vinorelbine) your healthcare provider recommends will vary, depending on a number of factors, including:
- Your height and weight
- Whether Navelbine is being used alone or in combination with other medicines
- How you respond to and tolerate the medication
- Other medical conditions you may have.
As is always the case, do not adjust your dosage unless your healthcare provider specifically tells you to do so.
The Navelbine dose your healthcare provider recommends will be based on your body surface area, which is normally calculated using your height and weight. Doses based on body surface area are written as mg per meter squared (mg per m2).
The standard dosage of Navelbine when used alone for the treatment of advanced non-small cell lung cancer is 30 mg per m2 once a week. Your healthcare provider may recommend you continue treatment until your cancer progresses or you develop serious side effects that prevent further doses from being given.
The usual recommended dosage of Navelbine when used in combination with cisplatin (Platinol®) for the treatment of advanced non-small cell lung cancer is 25 mg per m2 once a week. However, other doses are sometimes used.
Your healthcare provider will monitor the number of blood cells in your body using a simple blood test each week and adjust your Navelbine dose based on the results of these tests. Many people will require a dosage reduction because of low blood cell counts. In addition, people with liver disease may require lower amounts of Navelbine.